Intensity Therapeutics Analyst Ratings
Intensity Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $0.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $2.77, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 333.21% | Benchmark | → $12 | Reiterates | Speculative Buy → Speculative Buy |
| 08/24/2023 | 333.21% | Benchmark | → $12 | Reiterates | Speculative Buy → Speculative Buy |
| 07/18/2023 | 333.21% | Benchmark | → $12 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/14/2023 | 333.21% | 基准 | → 12 美元 | 重申 | 投机性买入 → 投机性买入 |
| 08/24/2023 | 333.21% | 基准 | → 12 美元 | 重申 | 投机性买入 → 投机性买入 |
| 07/18/2023 | 333.21% | 基准 | → 12 美元 | 启动覆盖范围开启 | → 投机性买入 |
What is the target price for Intensity Therapeutics (INTS)?
Intensity Therapeutics（INTS）的目标价格是多少？
The latest price target for Intensity Therapeutics (NASDAQ: INTS) was reported by Benchmark on November 14, 2023. The analyst firm set a price target for $12.00 expecting INTS to rise to within 12 months (a possible 333.21% upside). 3 analyst firms have reported ratings in the last year.
Benchmark于2023年11月14日公布了Intensity Therapeutics（纳斯达克股票代码：INTS）的最新目标股价。该分析公司将目标股价定为12.00美元，预计INTS将在12个月内升至12个月内（可能上涨333.21％）。去年有3家分析公司公布了评级。
What is the most recent analyst rating for Intensity Therapeutics (INTS)?
分析师对 Intensity Therapeutics (INTS) 的最新评级是多少？
The latest analyst rating for Intensity Therapeutics (NASDAQ: INTS) was provided by Benchmark, and Intensity Therapeutics reiterated their speculative buy rating.
Benchmark对Intensity Therapeutics（纳斯达克股票代码：INTS）的最新分析师评级由Benchmark提供，Intensity Therapeutics重申
When is the next analyst rating going to be posted or updated for Intensity Therapeutics (INTS)?
Intensity Therapeutics（INTS）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Intensity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Intensity Therapeutics was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Intensity Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Intensity Therapeutics的最新评级是在2023年11月14日公布的，因此您应该预计下一个评级将在2024年11月14日左右公布。
Is the Analyst Rating Intensity Therapeutics (INTS) correct?
分析师对强度疗法 (INTS) 的评级是否正确？
While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $0.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $2.77, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的Intensity Therapeutics（INTS）评级，目标股价为0.00美元至12.00美元。Intensity Therapeutics（INTS）目前的交易价格为2.77美元，在分析师的预测区间内。
